The Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People was the result of a meeting held at the Rockefeller Foundation Bellagio Center in the fall of 2012. The meeting was science based but policy oriented. The Bellagio Report concluded that: (1) sugar consumption, especially in the form of high-energy fructose in soft drinks, poses a major and insidious health threat, particularly for children; (2) current diets in most populations, albeit with regional differences, are deficient in omega-3 fatty acids but too high in omega-6 fatty acid intake, and (3) not all calories are the same since calories from different sources (i.e. glucose or fructose or omega-6 or omega-3 fatty acids) have different metabolic and neurohormonal effects. This paper summarizes the scientific progress and policy actions that have occurred in these three areas. Genetic variation in populations and gene-nutrient interactions are fundamental concepts that need to be taken into consideration in growth and development and in the prevention and management of chronic noncommunicable diseases since there is enormous variation in both the frequency of genetic variants and dietary composition worldwide. Furthermore, this paper updates the Bellagio Report in terms of the scientific and policy aspects, both of which have expanded over the past 2 years, and describes the progress made in establishing an International Network of Centers for Genetics, Nutrition and Fitness for Health.

Keywords:
Omega-6 and omega-3 essential fatty acids, Sugar, Glucose, Fructose, Calories, Genetic variation, Nutrition security, Policy considerations, International Network of Centers for Genetics, Nutrition and Fitness for Health
1.
Faergeman O, Hugenholtz PG, Caterina RD: Nutrition, food production and health - an agenda also for cardiologists. Eur J Prev Cardiol 2014, Epub ahead of print.
2.
World Health Organization: WHO opens public consultation on draft sugars guideline. March 15, 2014. http://www.who.int/mediacentre/news/notes/2014/consultation-sugar-guideline (accessed April 2014).
3.
Welsh JA, Sharma AJ, Grellinger L, Vos MB: Consumption of added sugars is decreasing in the United States. Am J Clin Nutr 2011;94:726-734.
4.
Kessler DA: Toward more comprehensive food labeling. N Engl J Med 2014;371:193-195.
5.
Sylvetsky AC, Dietz WH: Nutrient-content claims - guidance or cause for confusion? N Engl J Med 2014;371:195-198.
6.
Wilson J, Christensen J: Nutrition labels getting a makeover (for CNN). 2014. http://www.cnn.com/2014/02/27/health/nutrition-labels-changes/ (accessed February 2014).
7.
Lucan SC, DiNicolantonio JJ: How calorie-focused thinking about obesity and related diseases may mislead and harm public health. An alternative. Public Health Nutr 2014, Epub ahead of print.
8.
Sugar Action Group: Action Stations: Leading British nutrition scientists acknowledge now is time to take action on sugar. http://www.actiononsalt.org.uk/actiononsugar/Press%20Release%20/134223.html (accessed June 2014).
9.
BBC News: Mexico restricts soft drink TV ads to fight obesity. 2014. http://www.bbc.com/news/world-latin-america-28325105 (accessed July 2014).
10.
BBC News: Sugar tax may be necessary, England's chief medical officer says. 2014. http://www.bbc.com/news/health-26442420 (accessed March 2014).
11.
Calefati J: Health warning labels proposed for sodas, other sugary drinks sold in California. San Jose Mercury News, February 13, 2014. http://www.mercurynews.com/california/ci_25137374/health-warning-labels-proposedsodas-other-sugary-drinks.
12.
Moon RJ, Harvey NC, Robinson SM, Ntani G, Davies JH, Inskip HM, Godfrey KM, Dennison EM, Calder PC, Cooper C; SWS Study Group: Maternal plasma polyunsaturated fatty acid status in late pregnancy is associated with offspring body composition in childhood. J Clin Endocrinol Metab 2013;98:299-307.
13.
Swaminathan MS: Zero hunger. Science 2014;345:491.
14.
Simopoulos AP, Bourne PG, Faergeman O: Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People. Nutrients 2013;5:411-423.
15.
Haines A, Whitmee S, Horton R: Planetary health: a call for papers. Lancet 2014;384:479-480.
16.
Massougbodji J, Le Bodo Y, Fratu R, De Wals P: Reviews examining sugar-sweetened beverages and body weight: correlates of their quality and conclusions. Am J Clin Nutr 2014;99:1096-1104.
17.
Tasevska N, Park Y, Jiao L, Hollenbeck A, Subar AF, Potischman N: Sugars and risk of mortality in the NIH-AARP Diet and Health Study. Am J Clin Nutr 2014;99:1077-1088.
18.
Malik VS, Pan A, Willett WC, Hu FB: Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am J Clin Nutr 2013;98:1084-1102.
19.
Malik VS, Popkin BM, Bray GA, Despres JP, Hu FB: Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010;121:1356-1364.
20.
de Koning L, Malik VS, Kellogg MD, Rimm EB, Willett WC, Hu FB: Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation 2012;125:1735-1741.
21.
Bao Y, Stolzenberg-Solomon R, Jiao L, Silverman DT, Subar AF, Park Y, Leitzmann MF, Hollenbeck A, Schatzkin A, Michaud DS: Added sugar and sugar-sweetened foods and beverages and the risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study. Am J Clin Nutr 2008;88:431-440.
22.
Levi B, Werman MJ: Fructose and related phosphate derivatives impose DNA damage and apoptosis in L5178Y mouse lymphoma cells. J Nutr Biochem 2003;14:49-60.
23.
Abe R, Yamagishi S: AGE-RAGE system and carcinogenesis. Curr Pharm Des 2008;14:940-945.
24.
Hochuli M, Aeberli I, Weiss A, Hersberger M, Troxler H, Gerber PA, Spinas GA, Berneis K: Sugar-sweetened beverages with moderate amounts of fructose, but not sucrose, induce Fatty Acid synthesis in healthy young men: a randomized crossover study. J Clin Endocrinol Metab 2014;99:2164-2172.
25.
Marriott BP, Cole N, Lee E: National estimates of dietary fructose intake increased from 1977 to 2004 in the United States. J Nutr 2009;139:1228S-1235S.
26.
Welsh JA, Sharma A, Abramson JL, Vaccarino V, Gillespie C, Vos MB: Caloric sweetener consumption and dyslipidemia among US adults. JAMA 2010;303:1490-1497.
27.
Stanhope KL, Havel PJ: Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup. Am J Clin Nutr 2008;88:1733S-1737S.
28.
Aeberli I, Zimmermann MB, Molinari L, Lehmann R, l'Allemand D, Spinas GA, Berneis K: Fructose intake is a predictor of LDL particle size in overweight schoolchildren. Am J Clin Nutr 2007;86:1174-1178.
29.
de Koning L, Malik VS, Rimm EB, Willett WC, Hu FB: Sugar-sweetened and artificially sweetened beverage consumption and risk of type 2 diabetes in men. Am J Clin Nutr 2011;93:1321-1327.
30.
Aeberli I, Hochuli M, Gerber PA, Sze L, Murer SB, Tappy L, Spinas GA, Berneis K: Moderate amounts of fructose consumption impair insulin sensitivity in healthy young men: a randomized controlled trial. Diabetes Care 2013;36:150-156.
31.
Aeberli I, Gerber PA, Hochuli M, Kohler S, Haile SR, Gouni-Berthold I, Berthold HK, Spinas GA, Berneis K: Low to moderate sugar-sweetened beverage consumption impairs glucose and lipid metabolism and promotes inflammation in healthy young men: a randomized controlled trial. Am J Clin Nutr 2011;94:479-485.
32.
Dentin R, Girard J, Postic C: Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie 2005;87:81-86.
33.
Koo HY, Miyashita M, Cho BH, Nakamura MT: Replacing dietary glucose with fructose increases ChREBP activity and SREBP-1 protein in rat liver nucleus. Biochem Biophys Res Commun 2009;390:285-289.
34.
Koo HY, Wallig MA, Chung BH, Nara TY, Cho BH, Nakamura MT: Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver. Biochim Biophys Acta 2008;1782:341-348.
35.
Elliott SS, Keim NL, Stern JS, Teff K, Havel PJ: Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 2002;76:911-922.
36.
Mayes PA: Intermediary metabolism of fructose. Am J Clin Nutr 1993;58:754S-765S.
37.
Dekker MJ, Su Q, Baker C, Rutledge AC, Adeli K: Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2010;299:E685-E694.
38.
Chong MF, Fielding BA, Frayn KN: Mechanisms for the acute effect of fructose on postprandial lipemia. Am J Clin Nutr 2007;85:1511-1520.
39.
Parks EJ: Dietary carbohydrate's effects on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentrations. Br J Nutr 2002;87(suppl 2):S247-S253.
40.
Abdel-Sayed A, Binnert C, Le KA, Bortolotti M, Schneiter P, Tappy L: A high-fructose diet impairs basal and stress-mediated lipid metabolism in healthy male subjects. Br J Nutr 2008;100:393-399.
41.
Cox CL, Stanhope KL, Schwarz JM, Graham JL, Hatcher B, Griffen SC, Bremer AA, Berglund L, McGahan JP, Havel PJ, Keim NL: Consumption of fructose-sweetened beverages for 10 weeks reduces net fat oxidation and energy expenditure in overweight/obese men and women. Eur J Clin Nutr 2012;66:201-208.
42.
Roglans N, Vilà L, Farré M, Alegret M, Sánchez RM, Vázquez-Carrera M, Laguna JC: Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats. Hepatology 2007;45:778-788.
43.
Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, Graham JL, Hatcher B, Cox CL, Dyachenko A, Zhang W, McGahan JP, Seibert A, Krauss RM, Chiu S, Schaefer EJ, Ai M, Otokozawa S, Nakajima K, Nakano T, Beysen C, Hellerstein MK, Berglund L, Havel PJ: Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 2009;119:1322-1334.
44.
Schaefer EJ, Gleason JA, Dansinger ML: Dietary fructose and glucose differentially affect lipid and glucose homeostasis. J Nutr 2009;139:1257S-1262S.
45.
Lê KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, Boesch C, Tappy L: Fructose overconsumption causes dyslipidemia and ectopic lipid deposition in healthy subjects with and without a family history of type 2 diabetes. Am J Clin Nutr 2009;89:1760-1765.
46.
Lê KA, Faeh D, Stettler R, Ith M, Kreis R, Vermathen P, Boesch C, Ravussin E, Tappy L: A 4-week high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr 2006;84:1374-1379.
47.
Roberts R, Bickerton AS, Fielding BA, Blaak EE, Wagenmakers AJ, Chong MF, Gilbert M, Karpe F, Frayn KN: Reduced oxidation of dietary fat after a short term high-carbohydrate diet. Am J Clin Nutr 2008;87:824-831.
48.
InterAct Consortium; Romaguera D, Norat T, Wark PA, et al: Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia 2013;56:1520-1530.
49.
Ameur A, Enroth S, Johansson A, Zaboli G, Igl W, Johansson AC, Rivas MA, Daly MJ, Schmitz G, Hicks AA, Meitinger T, Feuk L, van Duijn C, Oostra B, Pramstaller PP, Rudan I, Wright AF, Wilson JF, Campbell H, Gyllensten U: Genetic adaptation of fatty-acid metabolism: a human-specific haplotype increasing the biosynthesis of long-chain omega-3 and omega-6 fatty acids. Am J Hum Genet 2012;90:809-820.
50.
Simopoulos AP: The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008;233:674-688.
51.
Xie L, Innis SM: Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J Nutr 2008;138:2222-2228.
52.
Caspi A, Williams B, Kim-Cohen J, Craig IW, Milne BJ, Poulton R, Schalkwyk LC, Taylor A, Werts H, Moffitt TE: Moderation of breastfeeding effects on the IQ by genetic variation in fatty acid metabolism. Proc Natl Acad Sci USA 2007;104:18860-18865.
53.
Martinelli N, Girelli D,Malerba G, Guarini P, Illig T, Trabetti E, SandriM, Friso S, Pizzolo F, Schaeffer L, Heinrich J, Pignatti PF, Corrocher R, Olivieri O: FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am J Clin Nutr 2008;88:941-949.
54.
Simopoulos AP: Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk. Exp Biol Med (Maywood) 2010;235:785-795.
55.
Mathias RA, Sergeant S, Ruczinski I, Torgerson DG, Hugenschmidt CE, Kubala M, Vaidya D, Suktitipat B, Ziegler JT, Ivester P, Case D, Yanek LR, Freedman BI, Rudock ME, Barnes KC, Langefeld CD, Becker LC, Bowden DW, Becker DM, Chilton FH: The impact of FADS genetic variants on u6 polyunsaturated fatty acid metabolism in African Americans. BMC Genet 2011;12:50.
56.
Allayee H, Baylin A, Hartiala J, Wijesuriya H, Mehrabian M, Lusis AJ, Campos H: Nutrigenetic association of the 5-lipoxygenase gene with myocardial infarction. Am J Clin Nutr 2008;88:934-940.
57.
Fradet V, Cheng I, Casey G, Witte JS: Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res 2009;15:2559-2566.
58.
Wang J, John EM, Ingles SA: 5-lipoxygenase and 5-lipoxygenase-activating protein gene polymorphisms, dietary linoleic acid, and risk for breast cancer. Cancer Epidemiol Biomarkers Prev 2008;17:2748-2754.
59.
O'Sullivan A, Armstrong P, Schuster GU, Pedersen TL, Allayee H, Stephensen CB, Newman JW: Habitual diets rich in dark-green vegetables are associated with an increased response to ω-3 fatty acid supplementation in Americans of African ancestry. J Nutr 2014;144:123-131.
60.
Browning LM, Walker CG, Mander AP, West AL, Gambell J, Madden J, Calder PC, Jebb SA: Compared with daily, weekly n-3 PUFA intake affects the incorporation of eicosapentaenoic acid and docosahexaenoic acid into platelets and mononuclear cells in humans. J Nutr 2014;144:667-672.
61.
Kiecolt-Glaser JK, Epel ES, Belury MA, Andridge R, Lin J, Glaser R, Malarkey WB, Hwang BS, Blackburn E: Omega-3 fatty acids, oxidative stress, and leukocyte telomere length: a randomized controlled trial. Brain Behav Immun 2013;28:16-24.
62.
Orchard TS, Ing SW, Lu B, Belury MA, Johnson K, Wactawski-Wende J, Jackson RD: The association of red blood cell n-3 and n-6 fatty acids with bone mineral density and hip fracture risk in the women's health initiative. J Bone Miner Res 2013;28:505-515.
63.
Mozaffarian D, Lemaitre RN, King IB, Song X, Huang H, Sacks FM, Rimm EB, Wang M, Siscovick DS: Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann Intern Med 2013;158:515-525.
64.
Kromhout D, de Goede J: Update on cardiometabolic health effects of omega-3 fatty acids. Curr Opin Lipidol 2014;25:85-90.
65.
Hodgson JM, Wahlqvist ML, Boxall JA, Balazs ND: Can linoleic acid contribute to coronary artery disease. Am J Clin Nutr 1993;58:228-234.
66.
Blankenhorn DH, Johnson RL, Mack WJ, el Zein HA, Vailas LI: The influence of diet on the appearance of new lesions in human coronary arteries. JAMA 1990;263:1646-1652.
67.
Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, Ringel A, Davis JM, Hibbeln JR: Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ 2013;346:e8707.
68.
Innis S: Metabolic programming of long-term outcomes due to fatty acid nutrition in early life. Matern Child Nutr 2011;7(suppl 2):112-123.
69.
Kanoski SE: Cognitive and neuronal systems underlying obesity. Physiol Behav 2012;106:337-444.
70.
Davidson TL, Sample CH, Swithers SE: An application of Pavlovian principles to the problems of obesity and cognitive decline. Neurobiol Learn Mem 2014;108C:172-184.
71.
Sheppard KW, Cheatham CL: Omega-6 to omega-3 fatty acid ratio and higher-order cognitive functions in 7- to 9-y-olds: a cross-sectional study. Am J Clin Nutr 2013;98:659-667.
72.
Simopoulos AP: Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease. Nutrients 2013;5:2901-2923.
73.
Agrawal R, Gomez-Pinilla F: ‘Metabolic syndrome' in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition. J Physiol 2012;590:2485-2499.
74.
Bremer AA, Stanhope KL, Graham JL, Cummings BP, Wang W, Saville BR, Havel PJ: Fructose-fed rhesus monkeys: a nonhuman primate model of insulin resistance, metabolic syndrome and type-2 diabetes. Clin Transl Sci 2011;4:243-252.
75.
Bremer AA, Stanhope KL, Graham JL, Cumming BP, Ampah SB, Saville BR, Havel PJ: Fish oil supplementation ameliorates fructose-induced hypertriglyceridemia and insulin resistance in adult male rhesus macaques. J Nutr 2014;144:5-11.
76.
Page KA, Chan O, Arora J, Belfort-Deaguiar R, Dzuira J, Roehmholdt B, Cline GW, Naik S, Sinha R, Constable RT, Sherwin RS: Effects of fructose versus glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways. JAMA 2013;309:63-70.
77.
Purnell JQ, Fair DA: Fructose ingestion and cerebral, metabolic, and satiety responses. JAMA 2013;309:85-86.
78.
Massiera F, Saint-Marc P, Seydoux J, Murata T, Kobayashi T, Narumiya S, Guesnet P, Amri EZ, Negrel R, Ailhaud G: Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern? J Lipid Res 2003;44:271-279.
79.
Riera-Crichton D, Tefft N: Macronutrients and obesity: revisiting the calories in, calories out framework. Econ Hum Biol 2014;14:33-49.
80.
Thomas JE: Mechanics and regulation of gastric emptying. Physiol Rev 1957;37:453-474.
81.
Simopoulos AP, Bourne PG, Faergeman O: Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People. J Nutrigenet Nutrigenomis 2013;6:34-42.
82.
Simopoulos AP, Bourne PG, Faergeman O: Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People (in French). Oleagineux Crops Gras Lipides 2013;20:1-6.
83.
Simopoulos AP, Bourne PG, Faergeman O: Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People. Rev Panam Salud Publica 2013;33:230-236.
84.
Simopoulos AP, Bourne PG, Faergeman O: Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People (in Spanish). Nutr Hosp 2013;26:1761-1769.
85.
Simopoulos AP, Bourne PG, Faergeman O: Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People (in Chinese). J Zhejiang Univ Agric Life Sci 2013;39:5-11.
86.
Simopoulos AP, Bourne PG, Faergeman O: Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People (in Portuguese). Estudos Avancados 2013;27:133-152.
87.
Simopoulos AP, Bourne PG, Faergeman O: Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People (in Greek). Hellenic Journal of Nutrition and Dietetics 2012;2:69-76.
88.
Simopoulos AP, Bourne PG, Faergeman O: Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People (in Hindi). New Dehli, Centre for Research on Nutrition Support Systems (CRNSS), 2014, pp 1-20.
89.
Simopoulos AP, Bourne PG, Faergeman O: Bellagio Report on Healthy Agriculture, Healthy Nutrition, Healthy People (in Italian). Agenzia Nazionale Stampa Associata Soc. Coop, in press.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.